Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

PACKAGING PROGRESS UPDATE

3 Oct 2013 07:00

RNS Number : 6006P
Xaar PLC
03 October 2013
 



 

3 October 2013

 

 

Xaar plc

 

 

PACKAGING PROGRESS UPDATE

 

 

Xaar plc ("Xaar", "the Group" or "the Company"), the inkjet printing technology Group headquartered in Cambridge, is pleased to issue an update on recent progress made in developing new opportunities in the packaging sector.

 

Xaar's market leading technology is at the heart of multiple innovative digital inkjet packaging solutions which were launched or demonstrated by Xaar's OEM partners at major exhibitions during September 2013.

 

· At Print 13 (8-12th September, Chicago) FFEI Ltd, a leading developer, manufacturer and supplier of digital imaging solutions, launched its new-generation Graphium digital UV inkjet printer. The product will be distributed by Fujifilm in both the USA and Europe. Xaar 1001 printheads were specified by FFEI to deliver the high productivity, reliability and quality that customers require for label, packaging and speciality print applications.

 

· At DRINKTEC (16-20th September 2013, Munich) four of Xaar's partner OEMs publicly demonstrated for the first time innovative "direct-to-shape" digital printing solutions. The four OEMs demonstrated systems which enable full colour images and text to be digitally printed directly onto glass, PET and metal containers, creating significant efficiencies through reductions in materials and inventory, improving time to market and eliminating many of the costs associated with using labels or sleeves. In addition, this technology allows digital decoration of irregular-shaped and textured containers which can pose a challenge for traditional labels and sleeves. It is expected that these offerings will now undergo a number of field trials which, if successful, will lead to the commercialisation of the technology.

 

· At Labelexpo Europe (24-27th September 2013, Brussels), Xaar's partner OEMs including ALS Engineering, Durst, EFI Jetrion, FFEI/Fujifilm, INX International, JF Machines and Stork Prints, all demonstrated their latest Xaar 1001-enabled labelling solutions which range from stand-alone entry-level systems for late-stage overprinting, to fully integrated systems for in-line graphics digital printing and finishing.

 

For further detail on these and other developments please go to www.xaar.com/news.aspx to access Xaar's latest news releases.

 

Ian Dinwoodie, Xaar's Chief Executive, commented:

 

"It is pleasing to see the progress being made in this significant market. Digital print of full colour graphic labels is clearly gaining traction in the packaging industry as evidenced by the strength of our OEMs' product line-up recently exhibited. The first public 'direct-to-shape' demonstrations clearly created an industry buzz, and we look forward to our partners moving through their field trials and into commercialisation. Whilst this recent activity is not expected to have any material impact on Xaar's 2013 financial results, the positive feedback received reinforces the potential for Xaar's technology to create transformational and disruptive solutions across multiple discrete markets".

 

END

 

 

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

Alex Bevis, Finance Director

Bankside Consultants:

020-7367-8888

Simon Bloomfield

Fiona Scholes

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAFSAESEFDSESS
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.